rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Streamex Corp.

STEX · Nasdaq

Health CareMedical DevicesNot moving yetTokenization/RWA

STEX stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 50 weeks. It is 59.3% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 50
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$8.5M
Insider sales, 12 months
$738K
Officials’ trades on record
0
Institutions holding
50 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$6.8MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months15
Sale orders, 12 months9
Buyers · sellers4 · 4
WhoDidSharesTraded
Christine Marie PlummerChief Financial Officersold13,344at $0.53771 Oct 2026filed 7 Oct 2026
Mitchell Young WilliamsChief Investment Officersold65,538at $0.53771 Oct 2026filed 7 Oct 2026
Mitchell Young WilliamsChief Investment Officersold72,689at $0.722 Sep 2026filed 3 Sep 2026
Morgan Lee LekstromInterim Executive Chairmanbought25,000at $1.0112 Jun 2026filed 15 Jun 2026
Morgan Lee LekstromInterim Executive Chairmanbought25,000at $0.9812 Jun 2026filed 15 Jun 2026
Mitchell Young WilliamsChief Investment Officersold23,810at $1.051 Jun 2026filed 2 Jun 2026
Morgan Lee LekstromInterim Executive Chairmanbought34,000at $1.4728 May 2026filed 28 May 2026
Morgan Lee LekstromInterim Executive Chairmanbought41,048at $1.0221 May 2026filed 21 May 2026
Morgan Lee LekstromInterim Executive Chairmanbought53,952at $1.0421 May 2026filed 21 May 2026
Morgan Lee LekstromInterim Executive Chairmanbought52,000at $1.0621 May 2026filed 21 May 2026
Anthony Mark MarcianoDirectorbought17,745.142at $1.1321 May 2026filed 22 May 2026
Mitchell Young WilliamsChief Investment Officersold263,863at $0.79481 May 2026filed 4 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders50-10 on the quarter
New · exited13 · 21
Reported value$18.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Legacy Wealth Managment, LLCreduced · filed 13 Aug 20266,530,074$5.6M-499,277−7.1%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20263,831,200$3.3M-126,794−3.2%
Yorkville Advisors Global, LPunchanged · filed 6 Aug 20263,750,000$3.2M00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,257,054$1.1M+338,267+36.8%
BlackRock, Inc.unchanged · filed 7 Aug 2026933,112$793K00.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026631,990$537K+204,882+48.0%
STATE STREET CORPadded · filed 7 Aug 2026603,990$514K+318,300+111.4%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026473,603$403K+71,999+17.9%
Rossby Financial, LCCadded · filed 4 Aug 2026385,030$327K+64,000+19.9%
UBS Group AGadded · filed 13 Aug 2026339,053$288K+164,930+94.7%
31 Dec 2023 – 30 Jun 2026
33158Dec 23Jun 24Jun 25Dec 25Jun 26

Everyone who traded it

Christine Marie Plummer Company insiderChief Financial Officer · last 1 Oct 20260 · 3
Mitchell Young Williams Company insiderChief Investment Officer · last 1 Oct 20261 · 4
Kevin Roy Gopaul Company insiderDirector · last 1 Jul 20260 · 0
Shawn Matthews Company insiderDirector · last 1 Jul 20260 · 0
Morgan Lee Lekstrom Company insiderInterim Executive Chairman · last 12 Jun 202611 · 1
Anthony Mark Marciano Company insiderDirector · last 21 May 20261 · 0
Karl Henry Michael McPhie Company insiderCEO · last 14 Apr 20260 · 1
Frank Giustra Company insider10% owner · last 4 Feb 20264 · 0
Donald Browne Company insiderDirector · last 18 Nov 20250 · 0
Ferdinand Groenewald Company insiderCFO · last 18 Nov 20250 · 0
Anthony N. Amato Company insiderDirector, 10% owner · last 29 May 20250 · 0
Christopher Allen Baer Company insiderDirector · last 24 Apr 20250 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-49.1%
Interest coverFY 2025 · to 31 Dec 2025-44.43×
Share count trendFY 2025 · to 27 Mar 202696.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$20.3M

Analyst forecasts

No analyst forecasts yet.